| Indicators | Browse All

Profusa, Inc. (PFSA)

Healthcare | Medical Devices | Berkeley, United States | NasdaqCM
1.29 USD -0.01 (-0.762%) ⇩ (Oct. 13, 2026, 10:54 a.m. EDT)

Short-term:★☆☆☆☆Long-term:☆☆☆☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 5:13 a.m. EDT

The immediate outlook is severely compromised by a catastrophic collapse in share price, which has erased nearly all historical value since the last major anchor point. While the recent 14-day window shows some volatility and a brief spike, the asset is currently trading at a fraction of its previous worth, indicating a massive market reassessment of the business's viability. This sharp decline is compounded by a complete absence of dividends and a balance sheet that appears fundamentally broken, with negative book value and significant debt relative to cash. The company is also navigating a chaotic period of corporate restructuring, including a drastic reverse stock split and a reduction in management equity grants, which signals internal turmoil rather than strategic clarity. Although the statistical forecasting model suggests a potential short-term bounce, its extremely low reliability score renders it useless for guiding investment decisions in such a distressed environment. The combination of deteriorating fundamentals, severe liquidity concerns, and ongoing compliance issues makes this a clear avoid for both short-term traders and long-term investors.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoARIMA ✓0.403895
AutoETS0.404535
MSTL0.423570
AutoTheta0.426238

Forecast horizon: 45 days | Selected: AutoARIMA

Forecast Reliability
Score 18%
H-stat 8.26
Ljung-Box p 0.000
Jarque-Bera p 0.000
Excess Kurtosis 5.40
Attribute Value
Sector Healthcare
Market Cap 781,345
Trailing P/E 0.00
Beta 0.50
Website https://profusa.com

Info Dump

Attribute Value
52 Week Change -0.9994354
Address1 626 Bancroft Way
Address2 Suite A
All Time High 41,250.0
All Time Low 1.25
Ask 1.9
Ask Size 1
Average Daily Volume10 Day 1,542,550
Average Daily Volume3 Month 2,744,044
Average Volume 2,744,044
Average Volume10Days 1,542,550
Beta 0.497
Bid 1.24
Bid Size 2
Book Value -205.029
City Berkeley
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 1.2901
Current Ratio 0.03
Custom Price Alert Confidence HIGH
Date Short Interest 1,790,726,400
Day High 1.31
Day Low 1.23
Display Name Profusa
Dividend Yield 0.0
Ebitda Margins 0.0
Enterprise Value 14,172,341
Eps Trailing Twelve Months 897.26
Esg Populated 0
Exchange NCM
Exchange Data Delayed By 15
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 3.63578
Fifty Day Average Change -2.3456802
Fifty Day Average Change Percent -0.6451656
Fifty Two Week Change Percent -99.94354
Fifty Two Week High 3,000.0
Fifty Two Week High Change -2,998.71
Fifty Two Week High Change Percent -0.99957
Fifty Two Week Low 1.23
Fifty Two Week Low Change 0.06009996
Fifty Two Week Low Change Percent 0.048861753
Fifty Two Week Range 1.23 - 3000.0
Financial Currency USD
First Trade Date Milliseconds 1,752,240,600,000
Float Shares 518,167
Free Cashflow -19,129,250
Full Exchange Name NasdaqCM
Fullday Change -0.009899974
Fullday Change Percent -0.7615365
Fullday Price 1.2901
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Has Pre Post Market Data 1
Held Percent Insiders 0.41706002
Held Percent Institutions 0.034879997
Implied Shares Outstanding 605,647
Industry Medical Devices
Industry Disp Medical Devices
Industry Key medical-devices
Ipo Expected Date 2,025-07-14
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,786,924,800
Last Split Factor 1:4
Long Business Summary Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.
Long Name Profusa, Inc.
Market us_market
Market Cap 781,345
Market State REGULAR
Max Age 86,400
Message Board Id finmb_141932876
Most Recent Quarter 1,782,777,600
Net Income To Common -42,970,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 1,241,738
Open 1.28
Operating Cashflow -20,330,000
Operating Margins 0.0
Payout Ratio 0.0
Phone 925 997 6925
Previous Close 1.3
Price Hint 4
Price To Book -0.0062922803
Profit Margins 0.0
Quick Ratio 0.026
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change -0.009899974
Regular Market Change Percent -0.7615365
Regular Market Day High 1.31
Regular Market Day Low 1.23
Regular Market Day Range 1.23 - 1.31
Regular Market Open 1.28
Regular Market Previous Close 1.3
Regular Market Price 1.2901
Regular Market Time 1,791,903,287
Regular Market Volume 58,692
Return On Assets -7.25255
Sand P52 Week Change 0.17502642
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 605,647
Shares Percent Shares Out 0.2653
Shares Short 160,653
Shares Short Previous Month Date 1,788,134,400
Shares Short Prior Month 39,618
Short Name Profusa, Inc.
Short Percent Of Float 0.26540002
Short Ratio 0.03
Source Interval 15
State CA
Symbol PFSA
Total Cash 719,000
Total Cash Per Share 1.187
Total Debt 14,104,000
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps 897.26
Trailing P E 0.0014378218
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 142.97516
Two Hundred Day Average Change -141.68506
Two Hundred Day Average Change Percent -0.99097675
Type Disp Equity
Volume 58,692
Website https://profusa.com
Zip 94,710